홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trifluoroacetic acid → Trifluoroacetic acid--3-aminopiperidine-2,6-dione (1/1)

HRID 533353
인쇄

반응식

HRID 533353 반응식
[O:1]=[C:2]1[CH:7]([NH:8]C(OC(C)(C)C)=O)[CH2:6][CH2:5][C:4](=[O:16])[NH:3]1.[C:17]([OH:23])([C:19]([F:22])([F:21])[F:20])=[O:18]>C(Cl)Cl>[F:20][C:19]([F:22])([F:21])[C:17]([OH:23])=[O:18].[NH2:8][CH:7]1[CH2:6][CH2:5][C:4](=[O:16])[NH:3][C:2]1=[O:1]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 6422Trifluoroacetic acidHCID 11310728tert-Butyl (2,6-dioxopiperidin-3-yl)carbamate

생성물 1

HCID 53447112Trifluoroacetic acid--3-aminopiperidine-2,6-dione (1/1)수율 99%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

2,6-Dioxo-3-aminopiperidine trifluoroacetate (4) was prepared and isolated as follows. Compound 3 (59 mg) was suspended in CH2Cl2 (5 mL). CF3COOH (0.5 mL) was added. The reaction solution was stirred at room for 4 h. The solvent was removed to give 4 (62 mg, 99%): 1H NMR (DMSO-d6) δ 11.42 (s, 1H), 8.70 (br, 2H), 4.31 (dd, J=5.4 Hz, J=13 Hz), 2.88-2.72 (m, 2H), 2.25-2.09 (m, 2H).

후처리

  1. custom2,6-Dioxo-3-aminopiperidine trifluoroacetate (4) was prepared
  2. customisolated
  3. customThe solvent was removed

출처 및 근거

ORD 기록
ord-17c5f884dc8e4c63b17eff94492a4db4
출처 데이터셋
uspto-grants-2014_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08853253B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트